MaxGrip was asked to assess and scope the asset performance improvement potential for a global healthcare company. The American multinational has a solid foundation with a lifetime of over 150 years, an annual revenue of over US$ 25 billion and operations in over 120 countries. Our consultants partnered with the pharmaceutical company to focus first on its Dutch production location. The asset management organization at the Dutch site understood and recognized its potential for maintenance and asset performance improvements.

Join for free to read